CXCR4 and small cell lung carcinoma: CXCR4 antagonists have been developed (Mousavi, 2020), and some activity has been detected in pre‐clinical models (Taromi et al, 2016); however, the relationship between CXCR4 and SCLC metastases has yet to be validated in models beyond in vitro and transplant models.